BridgeBio Pharma, Inc. Expense by Geography
No Expense by Geography for BBIO on this site yet.
- 2026-06-30: Products $10.53M; License, Services and Royalty $4.52M.
- 2025-06-30: Products $2.85M; License, Services and Royalty $805.00K.
Source checked: the stored Expense by Geography page for BBIO.
Expenses by product
Cost of sales: each quarter (3 month)
| Quarter end | Products | License, Services and Royalty |
|---|
| 2026-06-30 | $10.53M | $4.52M |
|---|
| 2025-06-30 | $2.85M | $805.00K |
|---|
Costs and Expenses: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $350.75M |
|---|
| 2025-06-30 | $244.84M |
|---|
Income Tax Expense (Benefit): each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $0.00 |
|---|
| 2025-06-30 | $2.10M |
|---|
Research and development: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $149.45M |
|---|
| 2025-06-30 | $111.23M |
|---|
Selling, General and Administrative Expense: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $186.26M |
|---|
| 2025-06-30 | $129.15M |
|---|